Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “RA PHARMACEUTICALS, INC.”

115 pharma patents match "RA PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 115
Index total 30,257
Page 5 / 5

Quick answer

This filtered view shows 115 pharmaceutical patents matching "RA PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

115 results for “RA PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 8440707

    Antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted

  2. US 8273780

    Polycyclic antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  3. US 8217066

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  4. US 8182835

    Sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted

  5. US 8058300

    Polycyclic antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  6. US 8048902

    Antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  7. US 7977359

    5-lipdxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  8. US 7919621

    Tricyclic inhibitors of 5-lipoxygenase

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  9. US 7834037

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted

  10. US 7795274

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted

  11. US 7405302

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  12. US 7309702

    Arylpiperazines having activity at the serotonin 1A receptor

    Avera Pharmaceuticals, Inc. · Granted Dec 18, 2007 · Expires Dec 13, 2027

    granted

  13. US 7001908

    Arylpiperazines having activity at the serotonin 1A receptor

    Avera Pharmaceuticals, Inc. · Granted Feb 21, 2006 · Expires Feb 16, 2026

    expired

  14. US 6395311

    Multicomponent biological vehicle

    Univera Pharmaceuticals, Inc. · Granted May 28, 2002 · Expires May 23, 2022

    expired

  15. US 6271214

    Process for the preparation of immunomodulatory polysaccharides from aloe

    Univera Pharmaceuticals, Inc. · Granted Aug 7, 2001 · Expires Aug 2, 2021

    expired

  16. US 6210680

    Method for the prevention and treatment of chronic venous insufficiency

    Univera Pharmaceuticals, Inc. · Granted Apr 3, 2001 · Expires Mar 29, 2021

    expired

  17. US 6133440

    Process for the preparation of immunomodulatory polysaccharides from aloe

    Univera Pharmaceuticals, Inc. · Granted Oct 17, 2000 · Expires Oct 12, 2020

    expired

  18. US 6123959

    Aqueous composition comprising active ingredients for the de-pigmentation of the skin

    Univera Pharmaceuticals, Inc. · Granted Sep 26, 2000 · Expires Sep 21, 2020

    expired

  19. US 6083976

    Method of synthesis of derivatives of aloesin

    Univera Pharmaceuticals, Inc. · Granted Jul 4, 2000 · Expires Jun 29, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.